![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, June 10, 2024 12:22:58 PM
Page 32 and 33 of the latest quarterly report:
On November 30, 2020, the Company consummated the Merger Agreement which involved the formation
of two wholly owned operating subsidiaries, Biogenysis, Inc., (“Biogenysis) and Virogentics, Inc.,
(“Virogentics”). Biogenysis was formed to acquire the intellectual property rights of, and license owned by,
certain officers of BioClonetics Immunotherapeutics, Inc., (“BioClonetics”) and Virogentics which was
formed to acquire the intellectual property rights of and licensed owned by a controlling stockholder of
Enzolytics. Both of the newly formed subsidiaries are Texas Corporations.
https://www.otcmarkets.com/otcapi/company/financial-report/403184/content
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM